Exhibit 99.9
AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares (represented by American Depositary Shares, each of which represents 15 Ordinary Shares) of Freeline Therapeutics Holdings plc and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. It is understood and agreed that the joint filing of the Schedule 13D shall not be construed as an admission that the persons named herein constitute a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934, as amended.
Dated: February 22, 2024
| SYNCONA PORTFOLIO LIMITED | ||
| By: | /s/ Robert Hutchinson | |
| Name: | Robert Hutchinson | |
| Title: | Director | |
| SYNCONA HOLDINGS LIMITED | ||
| By: | /s/ Robert Hutchinson | |
| Name: | Robert Hutchinson | |
| Title: | Director | |
| SYNCONA INVESTMENT MANAGEMENT LIMITED | ||
| By: | /s/ Christopher Hollowood | |
| Name: | Christopher Hollowood | |
| Title: | CEO | |
| SYNCONA LIMITED | ||
| By: | /s/ Robert Hutchinson | |
| Name: | Robert Hutchinson | |
| Title: | Director | |
| BIDCO 1354 LIMITED | ||
| By: | /s/ Alex Hamilton | |
| Name: | Alex Hamilton | |
| Title: | Director | |
| /s/ Roel Bulthuis |
| Roel Bulthuis |
| /s/ Christopher Hollowood |
| Christopher Hollowood |
